@article{15f7a438d63d424cb17d6646c5e0eb40,
title = "National Trends in Management of Pathologic Stage III Melanoma",
author = "Rhodin, \{Kristen E.\} and Farrow, \{Norma E.\} and Maria Xu and Jay Lee and Tyler, \{Douglas S.\} and Beasley, \{Georgia M.\}",
note = "Funding Information: Georgia Beasley has received clinical trial funding paid to Duke University from Delcath, Istari, Replimune, Oncosec, and Checkmate, and has served on a one-time advisory board for Cardinal Health and Regeneron. She is also supported by NIH K08 CA237726-01A1. Kristen E. Rhodin is supported by NIH 1R38AI140297. Norma E. Farrow, Maria Xu, Jay Lee, and Douglas S. Tyler have no disclosures to declare. ",
year = "2023",
month = may,
doi = "10.1245/s10434-023-13101-6",
language = "English (US)",
volume = "30",
pages = "2586--2589",
journal = "Annals of surgical oncology",
issn = "1068-9265",
publisher = "Springer Science and Business Media Deutschland GmbH",
number = "5",
}